Session 9: Technology, AI & Software
25 September 2026
The promise for pediatric Theranostics: Ai, technologic advances and clinical trial inclusion
Helen Nadel
Theranostics Automated Patient management tool
Doha Tantawy
Implementing Clinical Dosimetry with MIM Software: A Practical Approach
Partha Choudhury
Personalized dosimetry in Y90 SIRT: from empirical activity to quantitative Theranostics
Bharat Gupta
ANCORA.AI: THE RADIOPHARMACEUTICAL TRIAL DATABASE
Josh Mailman
coffee break
10:30AM - 11:00AM
Session 10: Thyroid Session
25 September 2026
ATA 2025: Is There Added Value?
Savvas Frangos
Intermediate postoperative risk of progression: A grey area in Radioiodine therapy
Tamara Geliashvili
Management of Differentiated metastatic thyroid cancer
Salah Eddine Bouyoucef
Molecular Redifferentiation: Therapeutic Paradigm in iodine-Refractory Metastatic Thyroid Cancer
Sze Ting
Challenges in the management of Paediatric DTC with I-131
Zabah Jawa
Imaging and Theranostics in medullary thyroid cancer
Michael Kreissl
Lunch break
12:30PM - 1:30PM
Session 11: NETs: Where Are We Now?
25 September 2026
Management strategy in NENs
Christos Toumpanakis
Experience using 177Lu and and 225Ac in NETS
Batool Albalooshi
¹⁷⁷Lu rechallenge and PRRT role in rare NETs
Irene Virgolini
Paediatric NET: Emerging role of theranostics and challenges
Zabah Jawa
Multidisciplinary Tumor Board: Case discussions
Moderator: Christos Toumpanakis
Coffee break
3:30PM - 04:00PM
Session 12: The Grand Finale: Quiz, Highlights & Closing Ceremony
25 September 2026
Think Fast! The Theranostics Quiz Session
Gopinath Gnanasegaran
Highlights summary
Yehia Omar